University of Pittsburgh Medical Center-Hillman Cancer Center is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Pittsburgh Medical Center-Hillman Cancer Center has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Non-small Cell Lung Cancer, Advanced Solid Tumor, Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen.
Sponsors: University of Texas Southwestern Medical Center, Xilio Development, Inc., Servier Bio-Innovation LLC.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Pittsburgh Medical Center-Hillman Cancer Center has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pittsburgh Medical Center-Hillman Cancer Center has 3 clinical trials on record, with 2 currently active. Their work covers Non-small Cell Lung Cancer, Advanced Solid Tumor, Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen.
University of Pittsburgh Medical Center-Hillman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.